Intensification strategies are available if patients with type 2 diabetes experience GLP1-RA therapy failure. Dr Riccardo Candido (Diabetes Center District 4, ASUGI, Trieste, Italy) discusses the current place of GLP1-RA therapy for the treatment of type 2 diabetes and the intensification strategies available following failure.
Dr Riccardo Candido presented an abstract entitled ‘Treatment Intensification after Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes—The RESTORE-G Real-World Study’ at the 82nd American Diabetes Association Scientific Session, June 3-7, 2022.
Questions:
- Please can you outline the current place of GLP1-RA therapy in the treatment of type 2 diabetes? (0:21)
- What intensification strategies are available following GLP1-RA therapy failure? (1:10)
Disclosures: Riccardo Candido has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of ADA 2022.
